Interpol deal with drug firms to fight fake medicines

Interpol on Tuesday announced a deal with the world's top pharmaceutical companies to fight fake drugs which threaten the health of millions, especially in poor countries.

Twenty-nine leading companies have pledged 4.5 million euros ($5.9 million) over three years to improve the fight against the counterfeit industry, boost public awareness and crack down on illegal manufacturers.

"With no country, no drug, no medical product immune from counterfeiting, a global effort is needed to combat this threat which puts the lives of millions of people at risk every single day," said Interpol Secretary General Ronald K. Noble.

Others highlighted the potentially deadly hazards of fake medicines.

"In the case of drug counterfeiting, it can mean the difference between life and death for a patient," said Christopher Viehbacher, the head of French drug firm Sanofi.

"It is estimated that 10 percent of medicines are fake and these figures can go up to 50 percent, particularly in some poorer countries."

According to the more than 50 percent of medicines bought online have been found to be fake.

Counterfeit and other medicines laced with diethylene glycol have caused eight mass around the world including in 2006 in Panama where more than 100 people died, many of them children, an Interpol statement said.

In 2012, some 109 in Pakistan died after taking fake medicine, it added.

add to favorites email to friend print save as pdf

Related Stories

Internet led to global 'explosion' of fake drugs

Jun 14, 2012

The rapid growth of Internet commerce has led to an explosion of counterfeit drugs sold around the world, with China the biggest source of fake medicines, pharmaceutical experts said Thursday.

China breaks up fake medicine racket

Nov 04, 2011

China said Friday it had busted a gang that produced and sold fake medicine -- some made of animal feed -- arresting 114 suspects and seizing more than 65 million counterfeit tablets.

Recommended for you

New system targets germs in donated blood plasma

1 hour ago

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

India court blocks Bayer generic drug appeal

Dec 13, 2014

An Indian court has rejected German drug giant Bayer's bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker, a move hailed by activists on Saturday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.